Live Webinar

Secondary Care Webinar 1 – Tackling the differential diagnosis of hypertrophic cardiomyopathy: ruling out other causes of left ventricular hypertrophy (First schedule)

Course Overview

This event will take place twice on April 11th, 2023
First schedule: 1pm EDT / 7pm CET
Second schedule: 7pm EDT / 1am CET (+1)

This expert webinar is designed to raise awareness for HCM and provide knowledge around a differential diagnosis for HCM. It assists secondary healthcare professionals to:

  • distinguish HCM from other diseases that may present similar symptoms
  • identify HCM features on an echocardiogram and a cardiac MRI

This webinar is 60 minutes duration.

Target audience

Cardiologists, echocardiographers, electrophysiologists, cardiac sonographers, cardiology nurses, nurse practitioners, registered nurses, physician assistants, pediatricians, pediatric nurses.

Funding disclosure

This activity is supported by educational grant funding from Bristol Myers Squibb and Cytokinetics. Learners may participate in this educational activity free of charge.

  • Introduction to hypertrophic cardiomyopathy (HCM)
  • Identifying hypertrophic cardiomyopathy: A case for diagnosis, differential diagnosis, or misdiagnosis
  • Testing for HCM: ECG and cMRI
  • Q&A and closing remarks

By the end of this activity, attendees will be able to:

  • summarize diagnostic differences between hypertrophic cardiomyopathy (HCM) and other diseases that can cause left ventricular hypertrophy (LVH) and apply this information to appropriately diagnose patients
  • identify features suggestive of HCM on an echocardiogram
  • outline electrocardiogram (ECG) findings that are suggestive of HCM and apply to an example patient
  • identify features suggestive of HCM on cardiac magnetic resonance (CMR) imaging

This activity will provide continuing education (CE) credits for physicians, physician assistants, nurses and nurse practitioners.

Dr Anjali Owens​, MD, Associate Professor of Medicine​, University of Pennsylvania​, has received financial compensation for consulting for Bristol Myers Squibb, Cytokinetics, Pfizer, Edgewise Therapeutics, Renovacor/Rocket, Stealth Biotherapeutics, Lexicon Pharmaceuticals, Tenaya Therapeutics, and received research grants from Bristol Myers Squibb and Cytokinetics.

Dr Stefano Nistri​, MD, Chief of Cardiology Services​​, CMSR Veneto Medica, Italy​​, has received financial compensation for speaker fees from Pfizer.

AffinityCE staff, PCM Scientific staff, as well as planners and reviewers have no relevant financial interests to disclose.

Mitigation of relevant financial relationships

AffinityCE adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CME activity, including faculty, planners, reviewers, or others, are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All relevant financial relationships have been mitigated prior to the commencement of the activity.